Marula Majesty Business Plan — Investment Thesis & Conclusion

Jump to sectionAll 19 pages
Section 15 · 16 of 19

Investment Thesis & Conclusion

Marula Majesty offers investors exposure to a rare asset: a globally scarce, uniquely African raw material feeding a fast-growing premium market, developed by a fully integrated operator with authentic community sourcing and genuine impact credentials. The strategic logic, organise supply, own processing, build brands, capture the value that currently leaks to intermediaries, is sound and defensible.

The bull case

  • A US$100 million and growing global oil market, feeding multi-billion-dollar beauty, wellness and food categories, with Southern Africa as the sole source of supply.
  • Full value-chain control and traceable, certified sourcing that command premium pricing and are hard to replicate.
  • Strong headline economics, R205 million revenue and R73 million EBITDA by Year 5, and attractive returns, with a ~R187 million enterprise NPV and ~52% project IRR.
  • Deep, measurable impact that unlocks concessional and impact capital alongside commercial funding.

What investors must underwrite

  • Liquidity: a committed revolving facility is essential to bridge the seasonal working-capital gap; without it the plan does not fund itself.
  • Execution: assembling world-class capability across agriculture, processing, branding and export simultaneously is the central risk.
  • Timing: net profitability arrives in Year 2, not Year 1, and orchard supply and brand equity mature later than the headline growth curve.
  • Terminal value: a meaningful share of returns depends on the exit multiple and scaled EBITDA.

We recommend the blended R65 million structure, R40 million equity, R20 million senior term debt and R5 million concessional funding, supported by a committed R30 million revolving working-capital facility, with disbursement of capital staged against the Section 11 milestones and covenanted on completion of key hires, certification and the first harvest. This structure aligns capital with the plan’s real risk profile: patient equity and concessional funding for the greenfield build and impact, term debt sized to comfortable coverage, and a revolver precisely matched to the seasonal cash cycle.

StrengthA fundamentally strong business, honestly financed

Underwritten on the re-derived numbers rather than the illustrative ones, and financed with a revolver that matches its seasonal cash cycle, Marula Majesty is a genuinely investable proposition: durable competitive advantages, a large value-capture opportunity, real impact, and returns that reward investors for the execution risk they are taking. The conditions for success are demanding but clear, and, importantly, they are within management’s control.